Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai White Cat Group is a prominent state-owned enterprise based in Shanghai, China, operating as a subsidiary of the Shanghai Huayi (Group) Company. While widely recognized for its dominant White Cat brand in the household detergent and cleaning agent markets, the group maintains a presence in the healthcare sector through its pharmaceutical manufacturing interests. Its subsidiary, Shanghai White Cat Pharmaceutical Co., Ltd., specializes in the production of over-the-counter (OTC) drugs and Traditional Chinese Medicine (TCM), including topical treatments and respiratory health products. The company's business model is centered on high-volume manufacturing and commercialization of consumer health and hygiene goods. As a legacy brand with significant regional influence, it plays a key role in the domestic Chinese market for basic pharmaceuticals and sanitary products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai White Cat Group.